
The ADVENT trial involving 593 patients with drug-refractory paroxysmal atrial fibrillation compared pulsed field ablation (PFA) and thermal ablation. While both methods showed no significant difference in 1-year freedom from atrial arrhythmias (AA), PFA excelled in reducing AA burden below 0.1%, a threshold linked to better quality of life and fewer clinical interventions. PFA proved especially effective for patients who had failed class I/III antiarrhythmic drugs, marking a significant advancement in AF treatment. (ADVENT.
Like
Save
Share